Form 8-K - Current report:
SEC Accession No. 0001683168-24-006053
Filing Date
2024-08-28
Accepted
2024-08-28 06:03:37
Documents
16
Period of Report
2024-08-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 55550
2 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION OF SONOMA sonoma_ex0301.htm EX-3.1 9062
3 PRESS RELEASE sonoma_ex9901.htm EX-99.1 13149
7 GRAPHIC image_001.jpg GRAPHIC 4134
  Complete submission text file 0001683168-24-006053.txt   272038

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snoa-20240823.xsd EX-101.SCH 3027
5 XBRL LABEL FILE snoa-20240823_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE snoa-20240823_pre.xml EX-101.PRE 24173
18 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3784
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 241250885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)